The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of RC48-ADC in HER2-positive patients with locally advanced or metastatic urothelial carcinoma.
 
Xinan Sheng
No Relationships to Disclose
 
Ai-Ping Zhou
No Relationships to Disclose
 
Xin Yao
No Relationships to Disclose
 
Yanxia Shi
No Relationships to Disclose
 
Hong Luo
No Relationships to Disclose
 
Benkang Shi
No Relationships to Disclose
 
Jiyan Liu
No Relationships to Disclose
 
Guohua Yu
No Relationships to Disclose
 
Zhisong He
No Relationships to Disclose
 
Changlu Hu
No Relationships to Disclose
 
Weiqing Han
No Relationships to Disclose
 
Jianmin Fang
Leadership - RemeGen
Stock and Other Ownership Interests - RemeGen
Patents, Royalties, Other Intellectual Property - Chengdu Kanghong Pharmaceutical Group., Ltd.; RemeGen
 
Jun Guo
No Relationships to Disclose